Pharmaceutical Excipient Development: The Need for Preclinical Guidance

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.32, Iss.2, 2000-10, pp. : 210-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of: "Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems"

By Brittain Harry G.

Pharmaceutical Development and Technology, Vol. 12, Iss. 1, 2007-01 ,pp. : 109-110

Informa Healthcare

Access to resources Recommend Favorite

Selected Pharmaceutical Excipient Prevent Isoniazid and Rifampicin Induced Hepatotoxicity

Current Drug Metabolism, Vol. 14, Iss. 6, 2013-01 ,pp. : 720-728

Bentham Science Publishers

Access to resources Recommend Favorite

The Development of Hyaluronan as a Drug Transporter and Excipient for Chemotherapeutic Drugs

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 4, 2008-08 ,pp. : 253-260

Bentham Science Publishers

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G Reily Michael D Baker J David

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

Preclinical development of therapeutic biologics

By Baumann Andreas

Expert Opinion on Drug Discovery, Vol. 3, Iss. 3, 2008-03 ,pp. : 289-297

Informa Healthcare

Access to resources Recommend Favorite